Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surgical resection margins after breast-conserving surgery: Senonetwork recommendations.
Galimberti V, Taffurelli M, Leonardi MC, Aristei C, Trentin C, Cassano E, Pietribiasi F, Corso G, Munzone E, Tondini C, Frigerio A, Cataliotti L, Santini D. Galimberti V, et al. Among authors: munzone e. Tumori. 2016 Jun 2;2016(3):284-9. doi: 10.5301/tj.5000500. Epub 2016 Apr 19. Tumori. 2016. PMID: 27103209 Review.
Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.
Joaquin Garcia A, Rediti M, Venet D, Majjaj S, Kammler R, Munzone E, Gianni L, Thürlimann B, Laáng I, Colleoni M, Loi S, Viale G, Regan MM, Buisseret L, Rothé F, Sotiriou C. Joaquin Garcia A, et al. Among authors: munzone e. Clin Cancer Res. 2023 Dec 1;29(23):4908-4919. doi: 10.1158/1078-0432.CCR-23-1267. Clin Cancer Res. 2023. PMID: 37733800
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
Pfeiler G, Hlauschek D, Mayer EL, Deutschmann C, Kacerovsky-Strobl S, Martin M, Meisel JL, Zdenkowski N, Loibl S, Balic M, Park H, Prat A, Isaacs C, Bajetta E, Balko JM, Bellet-Ezquerra M, Bliss J, Burstein H, Cardoso F, Fohler H, Foukakis T, Gelmon KA, Goetz M, Haddad TC, Iwata H, Jassem J, Lee SC, Linderholm B, Los M, Mamounas EP, Miller KD, Morris PG, Munzone E, Gal-Yam EN, Ring A, Shepherd L, Singer C, Thomssen C, Tseng LM, Valagussa P, Winer EP, Wolff AC, Zoppoli G, Machacek-Link J, Schurmans C, Huang X, Gauthier E, Fesl C, Dueck AC, DeMichele A, Gnant M; PALLAS Groups and Investigators. Pfeiler G, et al. Among authors: munzone e. J Clin Oncol. 2023 Nov 20;41(33):5118-5130. doi: 10.1200/JCO.23.00126. Epub 2023 Aug 9. J Clin Oncol. 2023. PMID: 37556775 Clinical Trial.
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U. Nolè F, et al. Among authors: munzone e. Ann Oncol. 1999 Aug;10(8):993-6. doi: 10.1023/a:1008389106575. Ann Oncol. 1999. PMID: 10509165 Free article. Clinical Trial.
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell'Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C, Neven P, Orosz Z, Olszewski WP, Knox F, Thürlimann B, Price KN, Castiglione-Gertsch M, Gelber RD, Gusterson BA, Goldhirsch A; Breast International Group Trial 1-98. Viale G, et al. J Clin Oncol. 2008 Dec 1;26(34):5569-75. doi: 10.1200/JCO.2008.17.0829. Epub 2008 Nov 3. J Clin Oncol. 2008. PMID: 18981464 Free PMC article. Clinical Trial.
Outcome of male breast cancer: a matched single-institution series.
Iorfida M, Bagnardi V, Rotmensz N, Munzone E, Bonanni B, Viale G, Pruneri G, Mazza M, Cardillo A, Veronesi P, Luini A, Galimberti V, Goldhirsch A, Colleoni M. Iorfida M, et al. Among authors: munzone e. Clin Breast Cancer. 2014 Oct;14(5):371-7. doi: 10.1016/j.clbc.2014.02.008. Epub 2014 Mar 1. Clin Breast Cancer. 2014. PMID: 24742826
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study.
Montagna E, Pagan E, Bagnardi V, Colleoni M, Cancello G, Munzone E, Dellapasqua S, Bianco N, Campennì G, Iorfida M, Mazza M, De Maio A, Veronesi P, Sangalli C, Scateni B, Pettini G, Pravettoni G, Mazzocco K, Galimberti V. Montagna E, et al. Among authors: munzone e. Breast Cancer Res Treat. 2020 Dec;184(3):783-795. doi: 10.1007/s10549-020-05900-2. Epub 2020 Sep 14. Breast Cancer Res Treat. 2020. PMID: 32929568
Management of breast cancer patients during the peak of the COVID 19 pandemic.
Montagna E, Bellerba F, Sangalli C, Gandini S, Cancello G, Aliaga PT, Galimberti V, Leonardi MC, Iorfida M, Munzone E, Mazza M, Dellapasqua S, Mastrilli F, Orecchia R, Malengo D, Omodeo Salè E, Viale G, Rietjens M, Colleoni M, Veronesi P. Montagna E, et al. Among authors: munzone e. Eur J Surg Oncol. 2021 Oct;47(10):2694-2695. doi: 10.1016/j.ejso.2021.05.037. Epub 2021 May 25. Eur J Surg Oncol. 2021. PMID: 34116901 Free PMC article. No abstract available.
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment.
Corso G, Kahler-Ribeiro-Fontana S, Pagan E, Bagnardi V, Magnoni F, Munzone E, Bottiglieri L, Veronesi P, Galimberti V. Corso G, et al. Among authors: munzone e. J Surg Oncol. 2021 Dec;124(8):1242-1250. doi: 10.1002/jso.26662. Epub 2021 Sep 1. J Surg Oncol. 2021. PMID: 34472105
125 results